Clinical Development

TranScrip Partners are mature and independent drug developers, experienced in setting the clinical strategy, design and implementation of clinical studies across major therapeutic areas. They can design, set up, coordinate, report and present on all clinical studies from Phase I through to Phase IV. They have had multiple interactions with US and European regulators (as well as potential development partners) and have an understanding of the diverse EU and US medical and regulatory environments needed to advise Clients on the appropriate adaptation of global clinical plans. Partners can thus contribute to overall clinical strategy and tactical delivery of clinical programmes, through preparation of proposals, set up and implementation of clinical studies, and optimisation of clinical development processes for the current pipeline and line extensions. They can contribute to the evaluation of preclinical candidates and/or represent Clients to third parties, such as other companies or government agencies.